Company: Paratek Pharmaceuticals
Job title: Executive Director, Head of Biometrics & Medical Writing
Marla Curran joined Paratek Pharmaceuticals in March 2018 as the newly created Head of Biometrics, reporting to the Chief Development Officer.
Dr. Curran has a strong track record in drug development and medical affairs, actively promoting innovative study methodology, including Bayesian design, and emphasizes integrated strategic planning. She is executing all scientific and operational aspects of Statistics, RWE and Medical Writing, which are critical in the design and implementation of development programs, regulatory submissions and interactions with global health authorities.
Before joining Paratek, Marla spent 2 years at Teva and 10 years at GSK, where she was Head of Medical Affairs Statistics, Director of Statistics, and RWE Director. Marla holds a DrPH and MS in Biostatistics, with emphasis in Epidemiology, from UNC-Chapel Hill, and a BS in Statistics from NCSU. Marla is an active mentor, participates in cross-industry initiatives and is passionate about scientific education and women’s leadership.
Impact of Real World Evidence Across the Life Cycle 11:15 am
• Synthesizing information and alignment: key data gaps, SWOT, functionspecific needs • Discussing big pharma vs. small pharma • Strategic planning framework: Challenges > Resolutions > Tactical Plan • Exploring stakeholder engagement and prioritization • The strength of evidence spectrum and optimizing trial/study designsRead more
day: Day Two